Showing results (61-70 of 1,869) with videos related to
Sort By:
Pageof 187
Current Cancer Drug Targets|November 30, 2007
Pathobiology of head and neck squamous tumorigenesisAdel K El-NaggarCurrent Cancer Drug Targets|November 30, 2007
Targeting angiogenesis in head and neck cancerNabil F Saba, Dong M Shin, Fadlo R KhuriCurrent Cancer Drug Targets|November 30, 2007
Targeting MDM2 and MDMX in retinoblastomaNikia A Laurie, Chie-Schin Shih, Chie Schin-Shih, et al.Current Cancer Drug Targets|March 15, 2006
Liposomal muramyl tripeptide phosphatidylethanolamine: Targeting and activating macrophages for adjuvant treatment of osteosarcomaA Nardin, M-L Lefebvre, K Labroquère, et al.Current Cancer Drug Targets|May 14, 2008
Genetically modified cellular vaccines for therapy of human papilloma virus type 16 (HPV 16)-associated tumoursJ BubenikCurrent Cancer Drug Targets|May 14, 2008
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implicationsAmancio Carnero, Carmen Blanco-Aparicio, Oliver Renner, et al.Current Cancer Drug Targets|May 14, 2008
Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemiaG Del Poeta, A Bruno, M I Del Principe, et al.Current Cancer Drug Targets|April 25, 2025
A Comprehensive Evaluation of the Effectiveness and Safety of Pembrolizumab for the Treatment of Metastatic Colorectal Cancer: A Systematic Review and Meta-AnalysisChao Huang, Yue He, Yidian Yang, et al.Current Cancer Drug Targets|April 28, 2025
Arctigenin Suppresses Melanoma via Mitophagy Activation In vitro and Enhances Dacarbazine Sensitivity In vivoLing Jiang, Yang Lu, Hongyan Zhao, et al.Current Cancer Drug Targets|April 25, 2025
Synergistic Targeting of EGFR, ESR1, BCL2, and TP53 Pathways: A Multi-Pronged Approach for Advanced Breast Cancer TherapyHarneet Marwah, Hitesh Kumar DewanganPageof 187